Literature DB >> 11355563

Melatonin prolongs survival of immunodepressed mice infected with the Venezuelan equine encephalomyelitis virus.

E Bonilla1, C Rodón, N Valero, H Pons, L Chacín-Bonilla, J Garcia Tamayo, Z Rodríguez, S Medina-Leendertz, F Añez.   

Abstract

Male albino mice immunodepressed after the injection of dexamethasone (DEX) were inoculated intraperitoneally with the Guajira strain of Venezuelan equine encephalomyelitis (VEE) virus. Melatonin (MLT) was administered daily, at a dose of 500 micrograms/kg bodyweight, for 3 days before virus inoculation and 10 days after. Serum levels of granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-2 (IL-2) were determined in all the experimental groups (control, DEX, DEX + MLT, DEX + VEE, DEX + VEE + MLT, VEE and MLT). At day 6 after the virus inoculation, the survival rate was significantly increased from 0% in group DEX + VEE to 32.5% in the group of immunodepressed infected mice treated with MLT (DEX + VEE + MLT). By day 10 a survival rate of 10% was found in group DEX + VEE + MLT and 0% in group VEE. No alterations in IL-2 serum levels were observed. MLT increased GM-CSF in control and in DEX-treated mice. In the VEE virus-infected mice treated with DEX, serum levels of GM-CSF increased progressively from day 1 to 5 postinoculation. In contrast, the levels of GM-CSF in infected immunodepressed mice treated with MLT decreased significantly from day 1 to 5 postinoculation. At day 5 after viral inoculation, no differences were detected in the cerebral viral titres in groups VEE, DEX + VEE and DEX + MLT + VEE. These results show that MLT does not inhibit VEE viral replication in the brain of immunodepressed mice.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11355563     DOI: 10.1016/s0035-9203(01)90170-1

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  11 in total

Review 1.  The role of melatonin in immuno-enhancement: potential application in cancer.

Authors:  Sandra C Miller; S R Pandi-Perumal; Perumal S R Pandi; Ana I Esquifino; Daniel P Cardinali; Georges J M Maestroni
Journal:  Int J Exp Pathol       Date:  2006-04       Impact factor: 1.925

Review 2.  A review of the multiple actions of melatonin on the immune system.

Authors:  Antonio Carrillo-Vico; Juan M Guerrero; Patricia J Lardone; Russel J Reiter
Journal:  Endocrine       Date:  2005-07       Impact factor: 3.633

3.  In vitro, melatonin treatment decreases nitric oxide levels in murine splenocytes cultured with the venezuelan equine encephalomyelitis virus.

Authors:  Nereida Valero; Eddy Meleán; Ernesto Bonilla; Julia Arias; Luz Marina Espina; Leonor Chacin-Bonilla; Yraima Larreal; Merybell Maldonado; Florencio Añez
Journal:  Neurochem Res       Date:  2005-11       Impact factor: 3.996

4.  Melatonin decreases nitric oxide production, inducible nitric oxide synthase expression and lipid peroxidation induced by Venezuelan encephalitis equine virus in neuroblastoma cell cultures.

Authors:  Nereida Valero; Luz Marina Espina; Jesus Mosquera
Journal:  Neurochem Res       Date:  2006-06-28       Impact factor: 3.996

Review 5.  Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization.

Authors:  B Farhood; N H Goradel; K Mortezaee; N Khanlarkhani; E Salehi; M S Nashtaei; H Mirtavoos-Mahyari; E Motevaseli; D Shabeeb; A E Musa; M Najafi
Journal:  Clin Transl Oncol       Date:  2018-08-22       Impact factor: 3.405

6.  Melatonin increases interleukin-1beta and decreases tumor necrosis factor alpha in the brain of mice infected with the Venezuelan equine encephalomyelitis virus.

Authors:  Ernesto Bonilla; Nereida Valero; Leonor Chacín-Bonilla; Héctor Pons; Yraima Larreal; Shirley Medina-Leendertz; Luz Marina Espina
Journal:  Neurochem Res       Date:  2003-05       Impact factor: 4.414

7.  Assessment of the Potential Role of Tryptophan as the Precursor of Serotonin and Melatonin for the Aged Sleep-wake Cycle and Immune Function: Streptopelia Risoria as a Model.

Authors:  Sergio D Paredes; Carmen Barriga; Russel J Reiter; Ana B Rodríguez
Journal:  Int J Tryptophan Res       Date:  2009-01-14

Review 8.  Beneficial actions of melatonin in the management of viral infections: a new use for this "molecular handyman"?

Authors:  Jose Antonio Boga; Ana Coto-Montes; Sergio A Rosales-Corral; Dun-Xian Tan; Russel J Reiter
Journal:  Rev Med Virol       Date:  2012-04-18       Impact factor: 6.989

Review 9.  Melatonin: buffering the immune system.

Authors:  Antonio Carrillo-Vico; Patricia J Lardone; Nuria Alvarez-Sánchez; Ana Rodríguez-Rodríguez; Juan M Guerrero
Journal:  Int J Mol Sci       Date:  2013-04-22       Impact factor: 5.923

10.  Urgent search for safe and effective treatments of severe acute respiratory syndrome: is melatonin a promising candidate drug?

Authors:  Stephen Y W Shiu; Russel J Reiter; Dun-Xian Tan; Shiu F Pang
Journal:  J Pineal Res       Date:  2003-08       Impact factor: 13.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.